Completed PHASE2 INTERVENTIONAL NCT00000641

A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Conditions HIV Infections Mycobacterium Avium-intracellulare Infection

Interventions Amikacin sulfate Azithromycin Ciprofloxacin hydrochloride Clofazimine Ethambutol hydrochloride Rifampin

Updated 7 times since 2017 Last updated: Oct 26, 2021 Completion: Dec 31, 1994

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00000641, this PHASE2 trial focuses on HIV Infections and Mycobacterium Avium-intracellulare Infection and remains completed. Sponsored by National Institute of Allergy and Infectious Diseases (NIAID), it has been updated 7 times since 2026, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Dec 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Dec 2021 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Allergy and Infectious Diseases (NIAID)

Data source: National Institute of Allergy and Infectious Diseases (NIAID)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Chapel Hill, United States , Cincinnati, United States , Cleveland, United States , Durham, United States , Greensboro, United States , Indianapolis, United States , New York, United States , Newark, United States , Pittsburgh, United States , Rochester, United States and 3 more locations